MaxCyte, Inc. (NASDAQ:MXCT) Q4 2025 Earnings Call Transcript March 24, 2026
MaxCyte, Inc. misses on earnings expectations. Reported EPS is $-0.09016 EPS, expectations were $-0.06505.
Operator: Good day, everyone, and welcome to MaxCyte, Inc.’s fourth quarter earnings conference call. At this time, all participants are in a listen-only mode. After the presentation, there will be a question-and-answer session. To participate, you will then hear a message advising your hand is raised. To...
